Jean-François D.
- Country
- Belgium
- Department
- Radiotherapy
Research Overview
- Phase II Randomized Study of Cisplatin and Radiotherapy Versus Durvalumab and Radiotherapy in Intermediate-Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma
- Phase III Randomized Study of Pembrolizumab and Stereotactic Ablative Radiotherapy in Oligometastatic Squamous Cell Carcinoma of the Head and Neck
Data & Insights
Has run more than one trial at 6 of 23 partner sites.
Specializations
Neuro-Oncology Focus
This investigator specializes in treating glioblastoma, conducting research into advanced therapeutic approaches for this aggressive form of brain cancer.
- Brain Tumor Treatment
- Recurrent Glioblastoma Management
- Brain Cancer Therapeutics
The investigator explores combination treatment strategies incorporating radiation therapy and chemotherapy for brain tumors.
Radiation Oncology
Expertise in reirradiation techniques for brain tumors, with particular focus on treating recurrent malignancies.
- Advanced Radiation Protocols
- Targeted Brain Radiotherapy
- Multimodal Treatment Approaches
The investigator studies innovative applications of radiation therapy in challenging neurological cases.
Treatment Innovation
Research interests include chemotherapeutic interventions with agents such as lomustine for brain cancer treatment.
- Drug Therapy Optimization
- Survival Outcome Studies
- Combined Treatment Strategies
The investigator evaluates therapeutic efficacy in progressive brain cancer scenarios.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.